SBHMY
Price
$8.34
Change
-$0.71 (-7.85%)
Updated
Dec 16 closing price
SYBX
Price
$1.37
Change
-$0.08 (-5.52%)
Updated
Dec 18, 04:59 PM (EDT)
Ad is loading...

SBHMY vs SYBX

Header iconSBHMY vs SYBX Comparison
Open Charts SBHMY vs SYBXBanner chart's image
Sino Biopharmaceutical
Price$8.34
Change-$0.71 (-7.85%)
Volume$161
CapitalizationN/A
Synlogic
Price$1.37
Change-$0.08 (-5.52%)
Volume$645
CapitalizationN/A
SBHMY vs SYBX Comparison Chart
Loading...
SBHMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
SBHMY vs. SYBX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SBHMY is a Hold and SYBX is a Hold.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (SBHMY: $8.34 vs. SYBX: $1.37)
Brand notoriety: SBHMY and SYBX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: SBHMY: 84% vs. SYBX: 115%
Market capitalization -- SBHMY: $7.52B vs. SYBX: $16.14M
SBHMY [@Biotechnology] is valued at $7.52B. SYBX’s [@Biotechnology] market capitalization is $16.14M. The market cap for tickers in the [@Biotechnology] industry ranges from $482.1B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

SBHMY’s FA Score shows that 1 FA rating(s) are green whileSYBX’s FA Score has 1 green FA rating(s).

  • SBHMY’s FA Score: 1 green, 4 red.
  • SYBX’s FA Score: 1 green, 4 red.
According to our system of comparison, SBHMY is a better buy in the long-term than SYBX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

SBHMY’s TA Score shows that 1 TA indicator(s) are bullish while SYBX’s TA Score has 6 bullish TA indicator(s).

  • SBHMY’s TA Score: 1 bullish, 3 bearish.
  • SYBX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, SYBX is a better buy in the short-term than SBHMY.

Price Growth

SBHMY (@Biotechnology) experienced а -7.90% price change this week, while SYBX (@Biotechnology) price change was -10.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -7.11%. For the same industry, the average monthly price growth was -2.34%, and the average quarterly price growth was +0.25%.

Reported Earning Dates

SYBX is expected to report earnings on Nov 09, 2023.

Industries' Descriptions

@Biotechnology (-7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
SBHMY($7.52B) has a higher market cap than SYBX($16.1M). SBHMY YTD gains are higher at: -7.742 vs. SYBX (-64.416). SBHMY has higher annual earnings (EBITDA): 6.98B vs. SYBX (-36.42M). SBHMY has higher revenues than SYBX: SBHMY (26.2B) vs SYBX (2.78M).
SBHMYSYBXSBHMY / SYBX
Capitalization7.52B16.1M46,714%
EBITDA6.98B-36.42M-19,161%
Gain YTD-7.742-64.41612%
P/E Ratio25.76N/A-
Revenue26.2B2.78M943,464%
Total CashN/A19.4M-
Total DebtN/A0-
FUNDAMENTALS RATINGS
SBHMY vs SYBX: Fundamental Ratings
SBHMY
SYBX
OUTLOOK RATING
1..100
9587
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
25
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9798
PRICE GROWTH RATING
1..100
5661
P/E GROWTH RATING
1..100
61100
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

SBHMY's Valuation (1) in the null industry is in the same range as SYBX (25) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to SYBX’s over the last 12 months.

SBHMY's Profit vs Risk Rating (100) in the null industry is in the same range as SYBX (100) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to SYBX’s over the last 12 months.

SBHMY's SMR Rating (97) in the null industry is in the same range as SYBX (98) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to SYBX’s over the last 12 months.

SBHMY's Price Growth Rating (56) in the null industry is in the same range as SYBX (61) in the Biotechnology industry. This means that SBHMY’s stock grew similarly to SYBX’s over the last 12 months.

SBHMY's P/E Growth Rating (61) in the null industry is somewhat better than the same rating for SYBX (100) in the Biotechnology industry. This means that SBHMY’s stock grew somewhat faster than SYBX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
SBHMYSYBX
RSI
ODDS (%)
Bullish Trend 3 days ago
43%
N/A
Stochastic
ODDS (%)
N/A
Bullish Trend 3 days ago
87%
Momentum
ODDS (%)
Bearish Trend 3 days ago
46%
Bullish Trend 3 days ago
87%
MACD
ODDS (%)
N/A
Bullish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
41%
Bullish Trend 3 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
43%
Bullish Trend 3 days ago
79%
Advances
ODDS (%)
N/A
Bullish Trend 9 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
N/A
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bearish Trend 3 days ago
46%
Bearish Trend 3 days ago
88%
View a ticker or compare two or three
Ad is loading...
SBHMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
SYBX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTCO2.350.15
+6.82%
Caravelle International Group
BAH135.800.24
+0.18%
Booz Allen Hamilton Holding Corp
AORT27.79-1.11
-3.84%
Artivion
VRNA40.06-1.60
-3.84%
Verona Pharma plc
AUST1.13-0.17
-13.08%
Austin Gold Corp

SBHMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, SBHMY has been loosely correlated with TENX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SBHMY jumps, then TENX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SBHMY
1D Price
Change %
SBHMY100%
N/A
TENX - SBHMY
42%
Loosely correlated
-4.99%
SYBX - SBHMY
34%
Loosely correlated
-5.52%
BTAI - SBHMY
32%
Poorly correlated
-8.95%
CLRPF - SBHMY
24%
Poorly correlated
+6.52%
TPIA - SBHMY
22%
Poorly correlated
+6.38%
More

SYBX and

Correlation & Price change

A.I.dvisor indicates that over the last year, SYBX has been loosely correlated with BNOX. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if SYBX jumps, then BNOX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SYBX
1D Price
Change %
SYBX100%
-5.52%
BNOX - SYBX
64%
Loosely correlated
-4.03%
BTAI - SYBX
42%
Loosely correlated
-8.95%
VCNX - SYBX
38%
Loosely correlated
-24.82%
SBHMY - SYBX
34%
Loosely correlated
N/A
MDGL - SYBX
31%
Poorly correlated
-4.35%
More